Concepedia
Statistics
Publications
31
Citations
1.2K
H-Index
20
Active since
1970
Affiliations
Central Drug Research Institute(Current)
Hebrew University of Jerusalem
Delhi Pharmaceutical Science and Research University
Georg Speyer Haus
The University of Texas Health Science Center at Tyler
Ashok Kumar is an author at Central Drug Research Institute specializing in pharmacology, life sciences, and drug discovery.
Publications per year
1970–2021
RUNX1 represses the erythroid gene expression program during megakaryocytic differentiation
Olga N. Kuvardina, Julia Herglotz, Stephan Kolodziej et al. · Blood · 2015 · 115 citations · Full text
Life Sciences, Genetics, Molecular Biology +9
Synthesis and bioevaluation of hybrid 4-aminoquinoline triazines as a new class of antimalarial agents
Ashok Kumar, Kumkum Srivastava, Sanjay Kumar et al. · Bioorganic & Medicinal Chemistry Letters · 2008 · 91 citations
Pharmacy, Medicinal Chemistry, Pharmacology +13
Synthesis of new 4-aminoquinolines and quinoline–acridine hybrids as antimalarial agents
Ashok Kumar, Kumkum Srivastava, Sanjay Kumar et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 79 citations
Pharmacy, Medicinal Chemistry, Pharmacology +15
Acetylation reduces <scp>SOX</scp> 9 nuclear entry <i> and <scp>ACAN</scp> </i> gene transactivation in human chondrocytes
Michal Bar Oz, Ashok Kumar, Jinan Elayyan et al. · Aging Cell · 2016 · 76 citations · Full text
Medicine, Cell Biology, Orthopaedic Surgery +17
4-Anilinoquinoline triazines: A novel class of hybrid antimalarial agents
Ashok Kumar, Kumkum Srivastava, Sunil Kumar et al. · European Journal of Medicinal Chemistry · 2010 · 74 citations
1–5 of 31